Are acquired demyelinating syndromes of the central nervous system underdiagnosed in Canadian children?
Publication year - 2004
Publication title -
paediatrics and child health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.55
H-Index - 43
eISSN - 1918-1485
pISSN - 1205-7088
DOI - 10.1093/pch/9.9.638
Subject(s) - medicine , central nervous system , demyelinating disorder , demyelinating disease , pediatrics
638 A six-year-old girl presents with acute visual loss (optic neuritis). Her magnetic resonance imaging scan shows multiple white matter lesions, consistent with demyelination. Will she recover completely? Will she continue to experience recurrent episodes of demyelination and, thus, meet the criteria for the chronic autoimmune disease, multiple sclerosis (MS)? The incidence of acute demyelination of the central nervous system in Canadian children is unknown. While not all children initially affected will go on to experience recurrent attacks characteristic of MS, their future remains uncertain. The risk of subsequent MS and the clinical, biological and neuroimaging predictors of MS risk have yet to be defined. Parents and health care professionals often do not consider MS a possible diagnosis based on an initial demyelinating event. The advent of disease-modifying therapies for MS and the recent evidence of improved long-term outcome associated with early therapy initiation emphasize the need for prompt diagnosis and coordinated care for children affected with MS. Are acquired demyelinating syndromes of the central nervous system underdiagnosed in Canadian children? CPSP HIGHLIGHTS
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom